Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |